SciVision Biotech (Taiwan) Alpha and Beta Analysis

1786 Stock  TWD 92.90  2.60  2.88%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as SciVision Biotech. It also helps investors analyze the systematic and unsystematic risks associated with investing in SciVision Biotech over a specified time horizon. Remember, high SciVision Biotech's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to SciVision Biotech's market risk premium analysis include:
Beta
(0.34)
Alpha
(0.49)
Risk
2.36
Sharpe Ratio
(0.21)
Expected Return
(0.48)
Please note that although SciVision Biotech alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, SciVision Biotech did 0.49  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of SciVision Biotech stock's relative risk over its benchmark. SciVision Biotech has a beta of 0.34  . As returns on the market increase, returns on owning SciVision Biotech are expected to decrease at a much lower rate. During the bear market, SciVision Biotech is likely to outperform the market. .
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out SciVision Biotech Backtesting, SciVision Biotech Valuation, SciVision Biotech Correlation, SciVision Biotech Hype Analysis, SciVision Biotech Volatility, SciVision Biotech History and analyze SciVision Biotech Performance.

SciVision Biotech Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. SciVision Biotech market risk premium is the additional return an investor will receive from holding SciVision Biotech long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in SciVision Biotech. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate SciVision Biotech's performance over market.
α-0.49   β-0.34

SciVision Biotech expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of SciVision Biotech's Buy-and-hold return. Our buy-and-hold chart shows how SciVision Biotech performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

SciVision Biotech Market Price Analysis

Market price analysis indicators help investors to evaluate how SciVision Biotech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading SciVision Biotech shares will generate the highest return on investment. By understating and applying SciVision Biotech stock market price indicators, traders can identify SciVision Biotech position entry and exit signals to maximize returns.

SciVision Biotech Return and Market Media

The median price of SciVision Biotech for the period between Tue, Sep 24, 2024 and Mon, Dec 23, 2024 is 102.5 with a coefficient of variation of 13.52. The daily time series for the period is distributed with a sample standard deviation of 14.21, arithmetic mean of 105.08, and mean deviation of 11.36. The Stock did not receive any noticable media coverage during the period.
 Price Growth (%)  
       Timeline  

About SciVision Biotech Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including SciVision or other stocks. Alpha measures the amount that position in SciVision Biotech has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards SciVision Biotech in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, SciVision Biotech's short interest history, or implied volatility extrapolated from SciVision Biotech options trading.

Build Portfolio with SciVision Biotech

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Additional Tools for SciVision Stock Analysis

When running SciVision Biotech's price analysis, check to measure SciVision Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SciVision Biotech is operating at the current time. Most of SciVision Biotech's value examination focuses on studying past and present price action to predict the probability of SciVision Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SciVision Biotech's price. Additionally, you may evaluate how the addition of SciVision Biotech to your portfolios can decrease your overall portfolio volatility.